These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 15478578)
1. Current topics in bone metastases. ONS News; 2004; 19(9 Suppl):35-6. PubMed ID: 15478578 [TBL] [Abstract][Full Text] [Related]
2. Metastatic bone disease and tumour-induced hypercalcaemia: treatment options. Heatley S Int J Palliat Nurs; 2004 Jan; 10(1):41-6. PubMed ID: 14966444 [TBL] [Abstract][Full Text] [Related]
3. The role of bisphosphonates in the management of advanced cancer with a focus on non-small-cell lung cancer. Part 2: Clinical studies and economic analyses. Saba N; Khuri F Oncology; 2005; 68(1):18-22. PubMed ID: 15775689 [TBL] [Abstract][Full Text] [Related]
5. [Symptom with bone metastasis--bone pain, fracture, hypercalcemia]. Toyoshi H Nihon Rinsho; 2007 Jan; 65(1):76-81. PubMed ID: 17233419 [TBL] [Abstract][Full Text] [Related]
6. The cost of treatment of skeletal-related events in patients with bone metastases from lung cancer. Delea T; Langer C; McKiernan J; Liss M; Edelsberg J; Brandman J; Sung J; Raut M; Oster G Oncology; 2004; 67(5-6):390-6. PubMed ID: 15713995 [TBL] [Abstract][Full Text] [Related]
7. Metastatic bone disease in the era of bone-targeted therapy: clinical impact. Ibrahim T; Farolfi A; Mercatali L; Ricci M; Amadori D Tumori; 2013; 99(1):1-9. PubMed ID: 23548992 [TBL] [Abstract][Full Text] [Related]
8. Bone metastases, general and clinical issues. Greco C; Forte L; Erba P; Mariani G Q J Nucl Med Mol Imaging; 2011 Aug; 55(4):337-52. PubMed ID: 21738111 [TBL] [Abstract][Full Text] [Related]
9. Managing skeletal related events resulting from bone metastases. Wilkinson AN; Viola R; Brundage MD BMJ; 2008 Nov; 337():a2041. PubMed ID: 18981017 [No Abstract] [Full Text] [Related]
10. Treatment of metastatic bone disease in breast cancer: bisphosphonates. Diel IJ; Solomayer EF; Bastert G Clin Breast Cancer; 2000 Apr; 1(1):43-51. PubMed ID: 11899389 [TBL] [Abstract][Full Text] [Related]
13. Clinical, economic and humanistic burdens of skeletal-related events associated with bone metastases. Carter JA; Ji X; Botteman MF Expert Rev Pharmacoecon Outcomes Res; 2013 Aug; 13(4):483-96. PubMed ID: 23862654 [TBL] [Abstract][Full Text] [Related]
14. [Epidemiology and clinical features of bone metastases]. Cvitkovic F; Mouret-Fourme E Bull Cancer; 2013 Nov; 100(11):1073-81. PubMed ID: 24169223 [TBL] [Abstract][Full Text] [Related]
16. Advances in the treatment of bone metastases. Reich CD Clin J Oncol Nurs; 2003; 7(6):641-6. PubMed ID: 14705479 [TBL] [Abstract][Full Text] [Related]
17. Bone metastases from advanced cancers: clinical implications and treatment options. Fitch M; Maxwell C; Ryan C; Löthman H; Drudge-Coates L; Costa L Clin J Oncol Nurs; 2009 Dec; 13(6):701-10. PubMed ID: 19948468 [TBL] [Abstract][Full Text] [Related]
18. Evaluating bone metastases. Albert K Clin J Oncol Nurs; 2007 Apr; 11(2):193-7. PubMed ID: 17573268 [No Abstract] [Full Text] [Related]
19. Cancer-induced bone disease. Drudge-Coates L; Turner B Nurs Stand; 2013 Jan 9-15; 27(19):48-56; quiz 57. PubMed ID: 23427627 [TBL] [Abstract][Full Text] [Related]
20. Bone metastases: pathogenesis, treatment, and rationale for use of resorption inhibitors. Scher HI; Yagoda A Am J Med; 1987 Feb; 82(2A):6-28. PubMed ID: 3548343 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]